{"transactions":[{"id":727792,"issuer":{"id":8214,"kind":"organization","name":"NuCana plc"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2026-06-24T07:09:38.000Z","date":"2026-06-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23811896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The ordinary shares, nominal value 0.000004 Pounds Sterling per share, of NuCana plc (the \"Company\") underlying this option were exercisable as of June 20, 2026, had an exercise price of 0.0004 Pounds Sterling per share, and were set to expire on June 20, 2035."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was canceled by mutual agreement of the Reporting Person and the Company. The Reporting Person did not receive consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The ordinary shares, nominal value 0.000004 Pounds Sterling per share, of NuCana plc (the \"Company\") underlying this option were exercisable as of June 20, 2026, had an exercise price of 0.0004 Pounds Sterling per share, and were set to expire on June 20, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The ordinary shares, nominal value 0.000004 Pounds Sterling per share, of NuCana plc (the \"Company\") underlying this option were exercisable as of June 20, 2026, had an exercise price of 0.0004 Pounds Sterling per share, and were set to expire on June 20, 2035."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23811896},"source":{"system":"sec-edgar","filing":"0001193125-26-280239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000119312526280239/ownership.xml","form_type":"4"}},{"id":730646,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2026-06-22T20:28:57.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027."}],"balance_after":51700,"derivative":{"exercise_price":2.55,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":51700},"source":{"system":"sec-edgar","filing":"0001650664-26-000068","document":"wk-form4_1782160133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000165066426000068/wk-form4_1782160133.xml","form_type":"4"}},{"id":1116468,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2025-06-10T20:18:49.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026."}],"balance_after":37500,"derivative":{"exercise_price":1.91,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001650664-25-000101","document":"wk-form4_1749586723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000165066425000101/wk-form4_1749586723.xml","form_type":"4"}},{"id":1472198,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T20:20:07.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.2,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-076263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000095017024076263/ownership.xml","form_type":"4"}},{"id":1495318,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T20:27:28.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024  and is scheduled to vest in full on May 30, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000058","document":"wk-form4_1717446440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000165066424000058/wk-form4_1717446440.xml","form_type":"4"}},{"id":1860850,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T20:05:09.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":18118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date."}],"balance_after":18118,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":18118},"source":{"system":"sec-edgar","filing":"0000899243-23-015146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000089924323015146/doc4.xml","form_type":"4"}},{"id":1920368,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-13T20:53:40.000Z","date":"2023-04-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 11, 2023 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on April 11, 2024 through April 11, 2026."}],"balance_after":50000,"derivative":{"exercise_price":6.71,"expiration_date":"2033-04-10","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-23-006521","document":"form4-04132023_080436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000141588923006521/form4-04132023_080436.xml","form_type":"4"}},{"id":2236352,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-06-10T20:10:36.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":18118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date."}],"balance_after":18118,"derivative":{"exercise_price":3.31,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":18118},"source":{"system":"sec-edgar","filing":"0000899243-22-021896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000089924322021896/doc4.xml","form_type":"4"}}]}